NEJM editor gives pretrial evidence in Vioxx case.
Tanne
Janice Hopkins
JH
D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D010506:Periodicals as Topic; D013450:Sulfones / Q000009:adverse effects*; D014481:United States
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib